BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 37497212)

  • 1. Current understanding of CTLA-4: from mechanism to autoimmune diseases.
    Hossen MM; Ma Y; Yin Z; Xia Y; Du J; Huang JY; Huang JJ; Zou L; Ye Z; Huang Z
    Front Immunol; 2023; 14():1198365. PubMed ID: 37497212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What did we learn from CTLA-4 insufficiency on the human immune system?
    Mitsuiki N; Schwab C; Grimbacher B
    Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy.
    Kim GR; Choi JM
    Mol Cells; 2022 Aug; 45(8):513-521. PubMed ID: 35950451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 regulates T follicular regulatory cell differentiation and participates in intestinal damage caused by spontaneous autoimmunity.
    Chao G; Li X; Ji Y; Zhu Y; Li N; Zhang N; Feng Z; Niu M
    Biochem Biophys Res Commun; 2018 Nov; 505(3):865-871. PubMed ID: 30301533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female-biased incidence of experimental autoimmune encephalomyelitis reflects sexually dimorphic expression of surface CTLA-4 (CD152) on T lymphocytes.
    Luna RM; K├Ârmendy D; Brunner-Weinzierl MC
    Gend Med; 2010 Aug; 7(4):296-308. PubMed ID: 20869630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.
    Jain N; Nguyen H; Chambers C; Kang J
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1524-8. PubMed ID: 20080649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 expressed by FOXP3
    Klocke K; Holmdahl R; Wing K
    Immunology; 2017 Sep; 152(1):125-137. PubMed ID: 28497863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation.
    Wing K; Yamaguchi T; Sakaguchi S
    Trends Immunol; 2011 Sep; 32(9):428-33. PubMed ID: 21723783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report.
    Kolcava J; Litzman J; Bednarik J; Stulik J; Stourac P
    Mult Scler Relat Disord; 2020 Oct; 45():102313. PubMed ID: 32623363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.
    Yamaguchi T; Kishi A; Osaki M; Morikawa H; Prieto-Martin P; Wing K; Saito T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):E2116-25. PubMed ID: 23690575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4: From mechanism to autoimmune therapy.
    Hosseini A; Gharibi T; Marofi F; Babaloo Z; Baradaran B
    Int Immunopharmacol; 2020 Mar; 80():106221. PubMed ID: 32007707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity.
    Schmidt EM; Wang CJ; Ryan GA; Clough LE; Qureshi OS; Goodall M; Abbas AK; Sharpe AH; Sansom DM; Walker LS
    J Immunol; 2009 Jan; 182(1):274-82. PubMed ID: 19109158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells control epitope spreading in autoimmune arthritis independent of cytotoxic T-lymphocyte antigen-4.
    Yang M; Klocke K; Hernandez CM; Xu B; Gjertsson I; Wing K; Holmdahl R
    Immunology; 2018 Dec; 155(4):446-457. PubMed ID: 29992549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4: a key regulatory point in the control of autoimmune disease.
    Scalapino KJ; Daikh DI
    Immunol Rev; 2008 Jun; 223():143-55. PubMed ID: 18613834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose interleukin-2 promotes STAT-5 phosphorylation, T
    Jeffery HC; Jeffery LE; Lutz P; Corrigan M; Webb GJ; Hirschfield GM; Adams DH; Oo YH
    Clin Exp Immunol; 2017 Jun; 188(3):394-411. PubMed ID: 28176332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 (CD152) blockade does not cause a pro-inflammatory cytokine profile in regulatory T cells.
    Kolar P; Hoff H; Maschmeyer P; Burmester GR; Brunner-Weinzierl MC
    Clin Exp Rheumatol; 2011; 29(2):254-60. PubMed ID: 21418778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
    Vogel I; Kasran A; Cremer J; Kim YJ; Boon L; Van Gool SW; Ceuppens JL
    Eur J Immunol; 2015 Jun; 45(6):1832-41. PubMed ID: 25727069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive function.
    Stumpf M; Zhou X; Chikuma S; Bluestone JA
    Eur J Immunol; 2014 Jun; 44(6):1737-46. PubMed ID: 24648182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis.
    Czaja AJ
    Autoimmunity; 2019 Jun; 52(4):144-160. PubMed ID: 31298041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.